# DOAC or VKA in Patients With AF and Stroke While on DOAC - a Pilot Trial

> **NCT07011095** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Population Health Research Institute** · enrollment: 100 (estimated)

## Conditions studied

- Atrial Fibrillation (AF)
- Stroke (in Patients With Atrial Fibrillation)

## Interventions

- **DRUG:** VKA
- **DRUG:** Direct Oral Anticoagulant (DOAC)

## Key facts

- **NCT ID:** NCT07011095
- **Lead sponsor:** Population Health Research Institute
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09-03
- **Primary completion:** 2027-02-03
- **Final completion:** 2027-06-03
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07011095

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07011095, "DOAC or VKA in Patients With AF and Stroke While on DOAC - a Pilot Trial". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07011095. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*